Rakuten Securities’s NovoCure NVCR Stock Holding History

Rakuten Securities’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258	Hold	17	–	–	﹤0.01%	819
2026 Q1	$185	Hold	17	–	–	﹤0.01%	803
2025 Q4	$220	Hold	17	–	–	﹤0.01%	815
2025 Q3	$220	Sell	17 -56	-77%	-$748	﹤0.01%	826
2025 Q2	$1.3K	Sell	73 -97	-57%	-$1.69K	﹤0.01%	635
2025 Q1	$3.03K	Hold	170	–	–	﹤0.01%	552
2024 Q4	$5.07K	Sell	170 -45	-21%	-$952	﹤0.01%	471
2024 Q3	$3.36K	Hold	215	–	–	﹤0.01%	461
2024 Q2	$3.68K	Sell	215 -72	-25%	-$1.27K	﹤0.01%	424
2024 Q1	$4.49K	Sell	287 -20	-7%	-$294	﹤0.01%	412
2023 Q4	$4.58K	Buy	+307	New	+$4.11K	﹤0.01%	357

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Rakuten Securities's NVCR Position: Q2 2026 in Review

Rakuten Securities held its NovoCure (NVCR) position steady in Q2 2026 at 17 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Rakuten Securities first reported a position in NVCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.07K in Q4 2024. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Rakuten Securities held 17 shares of NovoCure worth $258 as of Q2 2026.
Rakuten Securities left its NovoCure share count unchanged in Q2 2026.
NovoCure made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #819 holding.
Rakuten Securities first reported a position in NovoCure in Q4 2023 and has held it in 11 quarters since.
Rakuten Securities's NovoCure position peaked at $5.07K in Q4 2024.
216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.